Cleveland BioLabs Announces $4.2 Million Financing
Marketwired (press release) The offering consisted of 572,206 shares of common stock, plus an additional 583,856 shares of common stock subject to pre-funded warrants all at a price of $3.00 per share. An additional $750,000 was invested in preferred stock convertible into common … |